SG3 Management, LLC - NEUROBO PHARMACEUTICALS INC ownership

NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 31 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$167,000
-24.1%
50,0000.0%0.01%
+20.0%
Q1 2021$220,00050,0000.01%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 93,376$45,0000.03%
Murchinson Ltd. 205,256$98,0000.02%
Mount Yale Investment Advisors, LLC 57,425$28,0000.00%
TWO SIGMA SECURITIES, LLC 40,496$19,0000.00%
UBS Group AG 3,066$1,0000.00%
BANK OF AMERICA CORP /DE/ 240$00.00%
WELLS FARGO & COMPANY/MN 356$00.00%
NORTHERN TRUST CORP 17,155$8,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 438$00.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders